Facilitating Innovative Nuclear Diagnostics Act of 2023
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Facilitating Innovative Nuclear Diagnostics Act of 2023
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.
Forwarded by Subcommittee to Full Committee by Voice Vote.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 1199: Facilitating Innovative Nuclear Diagnostics Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-1199/
"H.R. 1199: Facilitating Innovative Nuclear Diagnostics Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-1199/.
H.R. 1199, 118th Cong. (2026), https://openamerica.io/bill/118-HR-1199/.
[H.R. 1199: Facilitating Innovative Nuclear Diagnostics Act of 2023](https://openamerica.io/bill/118-HR-1199/)